The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 743K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

27 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors.EBI
National Institute of Pharmaceutical Education and Research
Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3ß inhibitors.EBI
National Institute of Pharmaceutical Education and Research
Synthesis and biology of ring-modified l-Histidine containing thyrotropin-releasing hormone (TRH) analogues.EBI
National Institute of Pharmaceutical Education and Research
Synthesis of CNS active thyrotropin-releasing hormone (TRH)-like peptides: Biological evaluation and effect on cognitive impairment induced by cerebral ischemia in mice.EBI
National Institute of Pharmaceutical Education and Research
Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.EBI
National Institute of Pharmaceutical Education and Research
Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors.EBI
National Institute of Pharmaceutical Education and Research
Probing the binding site of curcumin in Escherichia coli and Bacillus subtilis FtsZ--a structural insight to unveil antibacterial activity of curcumin.EBI
National Institute of Pharmaceutical Education and Research
Quinolines and structurally related heterocycles as antimalarials.EBI
National Institute of Pharmaceutical Education and Research
New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies.EBI
National Institute of Pharmaceutical Education and Research
New PPARgamma ligands based on 2-hydroxy-1,4-naphthoquinone: computer-aided design, synthesis, and receptor-binding studies.EBI
National Institute of Pharmaceutical Education and Research
CoMFA analysis of dual/multiple PPAR activators.EBI
National Institute of Pharmaceutical Education and Research
Selectivity criterion for pyrazolo[3,4-b]pyrid[az]ine derivatives as GSK-3 inhibitors: CoMFA and molecular docking studies.EBI
National Institute of Pharmaceutical Education and Research
Design and synthesis of 6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid derivatives as PPARgamma activators.EBI
National Institute of Pharmaceutical Education and Research
Benzophenone: a ubiquitous scaffold in medicinal chemistry.EBI
National Institute of Pharmaceutical Education and Research
Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.EBI
National Institute of Pharmaceutical Education and Research
Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1.EBI
National Institute of Pharmaceutical Education and Research
Thyrotropin-releasing hormone (TRH) analogues that exhibit selectivity to TRH receptor subtype 2.EBI
National Institute of Pharmaceutical Education and Research
Synthesis and evaluation of S-4-(3-thienyl)phenyl-alpha-methylacetic acid.EBI
National Institute of Pharmaceutical Education and Research
Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity.EBI
National Institute of Pharmaceutical Education and Research
Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists.EBI
National Institute of Pharmaceutical Education and Research
Synthesis of 9-substituted derivatives of berberine as anti-HIV agents.EBI
National Institute of Pharmaceutical Education and Research
Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.EBI
National Institute of Pharmaceutical Education and Research
Antimalarials from nature.EBI
National Institute of Pharmaceutical Education and Research
Biomimetic synthesis and anti-HIV activity of dimeric phloroglucinols.EBI
National Institute of Pharmaceutical Education and Research
Tamarixetin 3-O-β-d-Glucopyranoside from Azadirachta indica Leaves: Gastroprotective Role through Inhibition of Matrix Metalloproteinase-9 Activity in Mice.EBI
National Institute of Pharmaceutical Education and Research
Triazine carboxamides as sodium channel blockersBDB
Purdue Pharma
Inhibitors of glucocorticoid receptor translocationBDB
Sanford Burnham Prebys Medical Discovery Institute